Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Organovo Holdings Inc (NYSE MKT LLC:ONVO)

3.76
Delayed Data
As of 2:15pm ET
 +0.04 / +1.08%
Today’s Change
1.60
Today|||52-Week Range
4.13
+51.00%
Year-to-Date
Why Organovo Holdings Inc. Is Up 27% This Year
Jun 30 / MotleyFool.com - Paid Partner Content
Organovo Isn't Worried About the Competition, But Should It Be?
Jun 27 / MotleyFool.com - Paid Partner Content
Strong On High Relative Volume: Organovo Holdings (ONVO)
Jun 28 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close3.72
Today’s open3.74
Day’s range3.68 - 3.90
Volume1,293,595
Average volume (3 months)665,748
Market cap$343.7M
Dividend yield--
Data as of 2:15pm ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)-13.16%
Earnings growth (this year)+1.16%
Earnings growth (next 5 years)--
Revenue growth (last year)+159.72%
P/E ratioNM
Price/Sales131.78
Price/Book5.53

Competitors

 Today’s
change
Today’s
% change
AGENAgenus Inc+0.13+3.09%
NDRMNeuroderm Ltd-0.30-1.85%
CGENCompugen Ltd+0.20+3.09%
VYGRVoyager Therapeutics...+0.24+2.18%
Data as of 2:28pm ET, 07/01/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$1.5M
Annual profit (last year)-$38.6M
Net profit margin-2,601.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Keith Murphy
Chief Scientific Officer
Sharon Collins Presnell
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs